Almirall, S.A. vs Johnson & Johnson
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $2.0 B for Almirall, S.A., 330 times as much (market caps of Jan 5, 2024 for Almirall, S.A. and Oct 29, 2026 for Johnson & Johnson). Almirall, S.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Johnson & Johnson had more revenue: $94.2 B against $1.2 B for Almirall, S.A., both in the year to December 2025.
- Johnson & Johnson earned more: net income of $26.8 B against $52 M for Almirall, S.A.
- Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against 4.2% for Almirall, S.A.
- Johnson & Johnson employs more people: 138,200 against 1,773 at Almirall, S.A. Each employee brings in about $704,597 of revenue at Almirall, S.A. and $681,570 at Johnson & Johnson.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Almirall, S.A. ALM.MC | Johnson & Johnson JNJ · #24 in the world |
|---|---|---|
| Profile | ||
| Country | 🇪🇸 Spain | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1943 | 1886 |
| Size | ||
| Market cap | $2.0 B* | $652.5 B |
| Revenue | $1.2 B | $94.2 B |
| Net income | $52 M | $26.8 B▲ best |
| Employees | 1,773 | 138,200 |
| Valuation | ||
| P/E ratio | — | 40.5× |
| Price to sales | — | 6.6× |
| Price to book | — | 8.0× |
| Free cash flow yield | — | 3.0% |
| Profitability | ||
| Operating margin | 6.6% | — |
| Net margin | 4.2% | — |
| Return on equity | 3.2% | — |
| Growth | ||
| Revenue growth | 17.1% | — |
| Earnings per share growth | 358.4% | — |
| Cash | ||
| Free cash flow margin | 12.6% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2024; ratios FY2025 | Market cap Oct 2026 |
Questions and answers#
Which is bigger, Almirall, S.A. or Johnson & Johnson?
Johnson & Johnson is the larger company by market value: $652.5 B against $2.0 B for Almirall, S.A., 330 times as much (market caps of Jan 5, 2024 for Almirall, S.A. and Oct 29, 2026 for Johnson & Johnson). Almirall, S.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Almirall, S.A. or Johnson & Johnson?
Johnson & Johnson had more revenue: $94.2 B against $1.2 B for Almirall, S.A., both in the year to December 2025. Johnson & Johnson earned more: net income of $26.8 B against $52 M for Almirall, S.A.
Which is more profitable, Almirall, S.A. or Johnson & Johnson?
Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against 4.2% for Almirall, S.A.
Which has more employees, Almirall, S.A. or Johnson & Johnson?
Johnson & Johnson employs more people: 138,200 against 1,773 at Almirall, S.A. Each employee brings in about $704,597 of revenue at Almirall, S.A. and $681,570 at Johnson & Johnson.